Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2025-12-26 @ 11:09 AM
Study NCT ID:
NCT03839550
Status:
UNKNOWN
Last Update Posted:
2019-02-15
First Post:
2019-02-11
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Combine Apatinib Mesylate With PD-1 Antibody SHR-1210 for HCC With High Risk of Recurrence After Radical Resection
Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization: